Our Expert in Canada
No results available
Last reviewed: August 6, 2026
Understanding how to determine patent term adjustment is now a critical compliance task for every patent owner with Canadian filings. Canada’s “additional term” regime, the country’s equivalent of patent term adjustment, took effect on January 1, 2025, following publication of the Regulations Amending the Patent Rules (SOR/2024‑241) in the Canada Gazette. The regime gives eligible patentees the right to extend protection beyond the standard 20‑year term, but only if they file an application with the Canadian Intellectual Property Office (CIPO) within a strict three‑month window after patent grant and pay the prescribed fee of CAD 1,027.
This guide walks in‑house counsel, patent agents and IP managers through the legal test, the step‑by‑step calculation, the procedural checklist, the 2026 fee schedule and the most common errors that can forfeit an otherwise valid claim to additional term.
Canada does have patent term adjustment, although the legislation uses the phrase “additional term” rather than the PTA acronym familiar to United States practitioners. The statutory authority sits in section 46.1 of the Patent Act, which empowers the Commissioner of Patents to grant an additional term where unreasonable delays attributable to the Patent Office occurred during prosecution. The operational rules, covering application requirements, calculation methodology and prescribed fees, are set out in the Patent Rules (SOR/2019‑251, as amended) and interpreted in detail in Chapter 32 of CIPO’s Manual of Patent Office Practice (MOPOP).
The regime recognises that some prosecution delays are beyond an applicant’s control and compensates for them by adding days to the end of the standard 20‑year patent term. It is conceptually similar to the United States PTA framework under 35 U.S.C. §154(b), but the Canadian system differs in important ways: applicants must affirmatively request the additional term, the calculation methodology tracks different delay categories, and there is a hard filing deadline that has no direct U.S. equivalent.
The additional term provisions were introduced through a multi‑stage process. The Regulations Amending the Patent Rules (SOR/2024‑241) were published in the Canada Gazette, Part II, on December 18, 2024. The amendments came into force on January 1, 2025. CIPO subsequently consolidated its operational guidance, including worked calculation examples and MyCIPO filing instructions, into MOPOP Chapter 32, with updates effective December 1, 2025. Stakeholders who had been monitoring the regulatory impact analysis statement in the Gazette now have a complete set of rules and guidance to work with.
Eligibility for patent term adjustment in Canada turns on two threshold questions: when the patent application was filed, and whether qualifying Patent Office delays occurred during prosecution. CIPO’s patents guide to additional term and MOPOP Chapter 32 set out the following core criteria:
Several scenarios require careful attention. Divisional applications inherit the filing date of the parent, which can affect both the eligibility threshold and the delay calculation. PCT national‑phase entries use the international filing date for threshold purposes but may have distinct prosecution timelines that alter the day count. Delays caused by the applicant, such as late responses to office actions, requests for extensions of time, or voluntary amendments, are deducted and do not contribute to additional term.
The core calculation method for how to determine patent term adjustment follows a three‑step framework set out in MOPOP Chapter 32. This framework is designed to isolate the number of days of unreasonable Patent Office delay and convert that figure into an additional term appended to the standard 20‑year expiry date.
Consider a hypothetical patent application with the following timeline:
| Event | Date | Day Count |
|---|---|---|
| Filing date | March 15, 2021 | , |
| Request for examination | March 15, 2023 | , |
| Later Date (later of filing + prescribed period or request for examination) | March 15, 2023 | Day 0 |
| Patent issue date | June 10, 2026 | Day 1,183 |
| Applicant delay (2 late responses totalling 120 days) | , | −120 |
| Additional term | , | 1,063 days |
In this example, the standard 20‑year patent term would expire on March 15, 2041 (20 years from the filing date). The additional term of 1,063 days extends protection to approximately February 11, 2044. The precise end date should be confirmed using the actual calendar and any adjustments required by the Patent Rules.
Industry observers note that three errors recur frequently. First, applicants sometimes fail to account for overlapping delay periods, where two types of delay run concurrently, the overlap must not be double‑counted. Second, maintenance fee payment timing can create confusion if a fee window straddles the transition from standard term to additional term; the CIPO maintenance schedule governs, and practitioners should cross‑check prorated amounts. Third, miscalculating the Later Date, particularly for divisional applications where the parent filing date governs, can inflate or deflate the gross period and produce an incorrect result.
The single most important deadline in the Canada PTA patent regime is the three‑month window. Under the Patent Rules, the application for additional term must be filed within three months following the date the patent is granted. Missing this deadline forfeits the right to additional term entirely, there is no late‑filing mechanism that resurrects an expired window.
| Milestone | Illustrative Date | Action |
|---|---|---|
| Patent issue date | June 10, 2026 | Calendar 3‑month deadline |
| Internal review complete | July 15, 2026 | Day‑count verified by patent counsel |
| Filing deadline | September 10, 2026 | Submit via MyCIPO + pay CAD 1,027 |
| CIPO decision (service standard) | ~November 2027 | Certificate or dismissal (~14 months) |
If CIPO dismisses the application, for example, because the calculation shows zero additional term or the documentation is deficient, the patentee may request reconsideration by paying an additional fee of CAD 1,027. A late fee of CAD 150 may also apply in certain circumstances specified in the Patent Rules. Practitioners should note that reconsideration is an administrative remedy; it does not extend the original three‑month filing deadline.
CIPO publishes prescribed fees for patent services on its Patent fees page. The following table summarises the fees relevant to additional term applications in 2026. All amounts are in Canadian dollars.
| Action | Fee (CAD) | Notes / Service Standard |
|---|---|---|
| Application for additional term (s. 46.1) | 1,027.00 | Certificate or dismissal within approximately 14 months of compliant application and fee payment. |
| Request for reconsideration of additional term | 1,027.00 | Same service standard applies to reconsideration decisions. |
| Maintenance fee (additional term period) | Per CIPO schedule (prorated) | Update to Canadian Patent Database (CPD) within 18 weeks of payment. Amounts depend on annuity year. |
| Late fee (s. 46.2(2)) | 150.00 | Applicable where the Patent Rules permit late compliance. |
The approximately 14‑month service standard means that patentees should not expect an immediate determination. For portfolio planning purposes, particularly in the pharmaceutical and biotechnology sectors where patent term directly affects market exclusivity, early indications suggest that building the 14‑month wait into product lifecycle models is becoming standard practice among corporate IP departments.
Practitioners with cross‑border portfolios benefit from understanding the structural differences between the Canadian and U.S. PTA regimes. The following comparison highlights the key distinctions.
| Feature | Canada, Additional Term (PTA) | United States, PTA |
|---|---|---|
| Legal basis | Patent Act s. 46.1 + Patent Rules (SOR/2019‑251, as amended) + MOPOP Chapter 32 | 35 U.S.C. §154(b), PTA for USPTO delays; different triggers and calculation categories (A, B, C delays) |
| Filing window | Patentee must apply within 3 months after patent issue date; no automatic grant | USPTO calculates PTA administratively and prints it on the patent; petitions available to correct errors |
| Fee and timing | Prescribed CIPO fee of CAD 1,027; certificate/dismissal service standard ~14 months | No separate PTA application fee; petition fees apply for recalculation requests |
| Applicant obligation | Must deduct applicant‑caused delays; affirmative filing required | Applicant may challenge or accept USPTO’s automatic calculation; reduction for applicant delay applies |
The most significant practical difference is that Canada requires an affirmative application with documentary support, while the United States calculates PTA automatically. Early indications suggest that this structural difference catches some multinational filers off guard, especially where U.S. counsel assume the Canadian patent office will handle adjustment without a separate filing.
Three categories of risk deserve attention when navigating patent term adjustment in Canada.
A recommended internal escalation path for corporate patent owners is: IP portfolio manager identifies upcoming grant → patent counsel runs the calculation and prepares the application → litigation lead reviews for Federal Court exposure (particularly in pharma/biotech PM(NOC) contexts where additional term affects regulatory data protection timelines).
Efficient compliance with the additional term regime requires standardised tools. The following resources can streamline the process:
Knowing how to determine patent term adjustment under Canada’s additional term regime is no longer optional for patent owners with significant Canadian portfolios. The compliance path is clear but unforgiving: confirm eligibility, run the three‑step calculation using MOPOP Chapter 32 methodology, and file the application via MyCIPO within three months of patent grant, accompanied by the prescribed CAD 1,027 fee. For complex portfolios, particularly in the pharmaceutical and biotechnology sectors where additional term can materially affect market exclusivity, PM(NOC) proceedings and competitive positioning, engaging experienced Canadian patent litigation counsel early in the process is strongly advisable. The stakes of missing the window, or submitting an inaccurate calculation, are permanent and irreversible.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Marian Wolanski at BELMORE NEIDRAUER LLP, a member of the Global Law Experts network.
posted 33 minutes ago
posted 57 minutes ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
posted 4 hours ago
posted 5 hours ago
posted 5 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message